A 1:1 THC:CBD Cannabis Extract Significantly Reduced Chronic Pain in German Patients

In 64 chronic pain patients in Germany, a THC25:CBD25 hybrid cannabis extract reduced average pain scores from 5.5 to 3.4 on a 10-point scale, with even larger improvements in cannabis-naïve patients (5.9 to 2.4).

Wagner, Yvonne et al.·Advances in therapy·2025·Moderate Evidenceclinical-observation
RTHC-07897Clinical ObservationModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
clinical-observation
Evidence
Moderate Evidence
Sample
N=64

What This Study Found

Mean pain intensity (NRS) decreased from 5.46 to 3.37 in the full population (n=64) and from 5.92 to 2.37 in cannabis-naïve patients (n=35). Pain interference also decreased substantially in both groups. Physical and mental health quality of life improved, and both patients and physicians reported high satisfaction.

Key Numbers

64 patients (ITT), 35 cannabis-naïve. Pain NRS: 5.46 → 3.37 (ITT), 5.92 → 2.37 (naïve). Pain interference: 5.39 → 3.38 (ITT), 5.68 → 2.54 (naïve). Both physical and mental health SF-12 scores improved. High patient and physician satisfaction.

How They Did This

ESCAPE: observational study of 64 patients (50% female) with chronic pain in Germany receiving Cannamedical Hybrid Cannabis Extract THC25:CBD25 across four clinical visits. Pain assessed by Brief Pain Inventory (NRS and interference), quality of life by SF-12. Cannabis-naïve patients analyzed as a pre-specified subgroup.

Why This Research Matters

Real-world evidence from clinical practice showing meaningful pain reduction with a balanced THC:CBD extract adds to the growing case for cannabis as a chronic pain treatment option, especially the impressive results in cannabis-naïve patients.

The Bigger Picture

The substantially greater improvement in cannabis-naïve patients (60% pain reduction vs 38% overall) suggests that first-time cannabis users may benefit most, possibly due to lack of tolerance. This has practical implications for prescribing decisions.

What This Study Doesn't Tell Us

Observational, no control group or blinding — cannot separate treatment effects from placebo, regression to mean, or natural course. Moderate sample size. Product-specific results may not generalize. Potential selection bias in physician-referred patients.

Questions This Raises

  • ?Would a randomized controlled trial confirm these results?
  • ?Is the balanced THC:CBD ratio important, or would THC-dominant or CBD-dominant extracts work as well?
  • ?Why do cannabis-naïve patients respond so much better?

Trust & Context

Key Stat:
Evidence Grade:
Observational real-world study with validated pain measures and pre-specified subgroup analysis, but no control group or blinding.
Study Age:
Published 2025.
Original Title:
How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical® Hybrid Cannabis Extract.
Published In:
Advances in therapy, 42(9), 4367-4389 (2025)
Database ID:
RTHC-07897

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Does cannabis work better for people who've never tried it?

In this study, cannabis-naïve patients had a 60% pain reduction compared to 38% overall. This may reflect lower tolerance, stronger placebo response, or genuine first-use benefit. More research is needed to confirm this pattern.

What does a 1:1 THC:CBD ratio mean?

The extract contained equal parts THC and CBD (25% each). The balanced ratio is thought to provide pain relief from THC while CBD may reduce THC side effects and add its own anti-inflammatory benefits.

Read More on RethinkTHC

Cite This Study

RTHC-07897·https://rethinkthc.com/research/RTHC-07897

APA

Wagner, Yvonne; Samel, Ines; Probst, Kristina; Schollenberger, Lukas; Ruckes, Christian; Nadstawek, Joachim. (2025). How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical® Hybrid Cannabis Extract.. Advances in therapy, 42(9), 4367-4389. https://doi.org/10.1007/s12325-025-03262-z

MLA

Wagner, Yvonne, et al. "How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical® Hybrid Cannabis Extract.." Advances in therapy, 2025. https://doi.org/10.1007/s12325-025-03262-z

RethinkTHC

RethinkTHC Research Database. "How to ESCAPE from Pain? An Observational Study on Improving..." RTHC-07897. Retrieved from https://rethinkthc.com/research/wagner-2025-how-to-escape-from

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.